Abstract
Interferon Response Factor 3 (IRF3) induces several NK-cell activating factors, is activated by poly-I:C, an experimental cancer therapeutic, but is suppressed during many viral infections. IRF3 Knockout (KO) mice exhibited enhanced B16 melanoma growth, impaired intratumoral NK cell infiltration, but not an impaired poly-I:C therapeutic effect due to direct suppression of B16 growth. IRF3 was responsible for poly-I:C decrease in TIM-3 expression by intratumoral dendritic cells, induction of NK-cell Granzyme B and IFN-γ, and induction of macrophage IL-12, IL-15, IL-6, and IRF3-dependent NK-activating molecule (INAM). Thus, IRF3 is a key factor controlling melanoma growth through NK-cell activities, especially during poly-I:C therapy.
Original language | English (US) |
---|---|
Pages (from-to) | 122-128 |
Number of pages | 7 |
Journal | Cancer Letters |
Volume | 346 |
Issue number | 1 |
DOIs | |
State | Published - Apr 28 2014 |
Keywords
- Cytokines
- IRF3
- Melanoma
- NK-cells
- Poly-I:C
ASJC Scopus subject areas
- Oncology
- Cancer Research